EDGAR Filing Documents for 0001213900-22-074323

Form 8-K - Current report:

SEC Accession No. 0001213900-22-074323

Filing Date

2022-11-22

Accepted

2022-11-21 19:02:30

Documents

Period of Report

2022-11-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea169087-8k_inmedpharma.htm iXBRL	8-K	56603
2	FORM OF PRE-FUNDED WARRANT	ea169087ex4-1_inmedpharma.htm	EX-4.1	100037
3	FORM OF PREFERRED INVESTMENT OPTION	ea169087ex4-2_inmedpharma.htm	EX-4.2	105512
4	FORM OF PLACEMENT AGENT PREFERRED INVESTMENT OPTION	ea169087ex4-3_inmedpharma.htm	EX-4.3	104710
5	FORM OF SECURITIES PURCHASE AGREEMENT	ea169087ex10-1_inmedpharma.htm	EX-10.1	232331
6	REGISTRATION RIGHTS AGREEMENT	ea169087ex10-2_inmedpharma.htm	EX-10.2	165245
7	PRESS RELEASE DATED NOVEMBER 18, 2022	ea169087ex99-1_inmedpharma.htm	EX-99.1	13641
8	PRESS RELEASE DATED NOVEMBER 21, 2022	ea169087ex99-2_inmedpharma.htm	EX-99.2	13527
9	GRAPHIC	ex99-1_001.jpg	GRAPHIC	5102
10	GRAPHIC	ex99-2_001.jpg	GRAPHIC	5109
	Complete submission text file	0001213900-22-074323.txt		1169260

Data Files

Seq	Description	Document	Type	Size
11	XBRL SCHEMA FILE	inm-20221121.xsd	EX-101.SCH	3233
12	XBRL LABEL FILE	inm-20221121_lab.xml	EX-101.LAB	34240
13	XBRL PRESENTATION FILE	inm-20221121_pre.xml	EX-101.PRE	22364
15	EXTRACTED XBRL INSTANCE DOCUMENT	ea169087-8k_inmedpharma_htm.xml	XML	3753

Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4

Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207

InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)